Surrozen, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Craig C. Parker, with a market cap of $315.3M.
Common questions about Surrozen, Inc.
Surrozen, Inc. is scheduled to report earnings for Q1 2026 on May 8, 2026. Analysts estimate revenue of $5.2M.
Surrozen, Inc. has approximately 42 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.